Vizgen
Provides spatial genomics platforms for single-cell gene expression profiling.
Company facts
- Founded
- 2019
- Employees
- 166
- Headquarters
- United States
- CEO
- Terry Lo
- Type
- Private
- Funding
- Series E · $48M · 2026
- Subsidiaries
- Ultivue
About
At Vizgen, we are pioneering the field of spatial genomics, reshaping how researchers understand complex biological systems. Our primary focus is on developing the MERSCOPE platform, which integrates single-cell and spatial multiomics analysis powered by MERFISH technology. This innovative technology allows researchers to visualize gene expression in situ, providing high-resolution insights into the cellular makeup of tissues. Founded in 2019, Vizgen has quickly positioned itself as a leader in spatial transcriptomics. Our mission is to enable breakthroughs in biological research by providing advanced tools that enhance the study of gene function and pathology. With our MERFISH technology, we empower researchers to explore gene expression patterns with unparalleled precision, supporting significant advancements in understanding diseases such as cancer and neurological disorders.